2024 annual financial data
Oncolytics Biotech 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -25,542,000 CAD and net income was -22,794,000 CAD.
Operating cash flow was -19,883,000 CAD.
Get free Oncolytics Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -25,542,000 CAD
- Net income
- -22,794,000 CAD
- Operating cash flow
- -19,883,000 CAD